)
Edge28 Nov 2025
Keeping the Streak Alive: The Story of Duolingo
How Duolingo made language learning addictive, scaled to millions of users, and built a powerful subscription business around everyday practice.
Emcure Pharmaceuticals (EMCURE) investor relations material
Emcure Pharmaceuticals Q2 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 25/26 earnings summary11 Nov, 2025
Executive summary
Achieved 13.4% year-over-year revenue growth to INR 2,270 crore and record quarterly profit of INR 251 crore, with 24.7% PAT growth in Q2 FY2026.
Sustained momentum across all business segments, with both domestic and international markets outperforming industry growth.
Strategic partnership with Novo Nordisk for semaglutide (Poviztra) positions the company as an early entrant in India's obesity market.
Completed acquisition of minority stake in Zuventus, enabling full consolidation and expected backend synergies.
EBITDA for the quarter reached INR 439 crore, up 15.2% year-over-year, with EBITDA margin at 19.3%.
Financial highlights
Revenue from operations grew 13.4% year-over-year to INR 2,270 crore.
Domestic business up 10.6% year-over-year to INR 1,031 crore; international business up 15.8% to INR 1,238 crore.
Europe revenue rose 22.7% to INR 444 crore; Canada up 17.5% to INR 348 crore; emerging markets up 8.6% to INR 446 crore.
Gross margin at 60.8% (vs. 60.6% last year); EBITDA margin at 19.3%.
PAT at INR 251 crore, up 24.7% year-over-year; net debt at INR 837 crore, increased due to Zuventus stake purchase.
Outlook and guidance
On track to deliver high-level guidance for the year, with expectations to grow above industry rates.
Base EBITDA margins expected to improve by 150 basis points for FY2026, excluding new in-licensing deals.
Debt-free target revised to end of next year (18-24 months), post Zuventus acquisition.
Focus remains on portfolio expansion in key markets through in-licensing and in-house development.
Second half of the year expected to see stronger operating margin improvement and continued growth in all key markets.
Expected financial impact of Zuventus becoming WOS
Purpose of significant increase in borrowings
Market impact of Novo Nordisk Poviztra partnership?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Emcure Pharmaceuticals earnings date
Q3 25/265 Feb, 2026
Next Emcure Pharmaceuticals earnings date
Q3 25/265 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Emcure Pharmaceuticals Limited is an India-based pharmaceutical company involved in the development, manufacturing, and marketing of a broad range of pharmaceutical products. Emcure’s product portfolio includes prescription medicines, biologics, and over-the-counter products, covering therapeutic areas such as cardiology, oncology, nephrology, and anti-infectives. The company operates manufacturing facilities in India and has a significant presence in both domestic and international markets. The company is headquartered in Pune, India.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage